Look at Ways in Which Companies Can Develop Pain Drugs & Treatments at Pain Therapeutics 2012

London, United Kingdom, May 02, 2012 --(PR.com)-- Pain is an incredibly hot topic as it affects all illnesses and all people, in many different ways. This makes it an incredibly lucrative business and one that has not yet been explored in the pharmaceutical industry to its full potential. Pain is also the most common reason patients seek medical care, as it affects the quality of life many people experience and has significant sensory and emotional components. Whilst advances have been made in pain management, few significant ones have occurred, making it harder in recent years to get analgesics to market.

In the current economic climate, this makes it even more imperative for companies to improve their R&D methods so that drugs being put forward for clinical trials have the best chance of success. With only 3 weeks to go, don’t miss out on this exciting event and register today.

Hear key presentations from industry-leading experts:
· Chas Bountra, Professor of Translational Medicine, Head, Structural Genomics Centre Oxford University
· Jonathan Stewart, Disease Area Head, Neuroscience, Immunology and Pain, Bristol-Myers Squibb
· Jason Witherington, Head of Chemistry, GlaxoSmithKline
· Philip Kym, Associate Director II Pain Discovery Research, Abbott
· Mark Bowlby, Neurophysiology and Pain Lead, Merck
· Dave Shelton, Senior Director, Pfizer Global Research & Development
· Jaymin Upadhyay, Senior Scientist II Translational Sciences, Abbott Laboratories

Network with our registered attendees:
· Mundipharma Research GmbH & Co. KG
· Antwerp University Hospital
· Helsinn Healthcare
· Grünenthal GmbH
· Orion Corporation
· Pfizer Ltd
· Ricerca Biosciences
· Aquila BioMedical
· Esteve
· Astellas Pharma Kft
· NsGene
· University of Bristol

Visit www.pain-therapeutics.co.uk for more information or to register your place. Alternatively, contact Jay Clements at Tel: +44 (0)20 7827 6734 or Email: jclements@smi-online.co.uk

About SMi Group
Pain Therapeutics 2012 is just one of the many conferences that are a part of the SMi Group portfolio. The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information, visit www.smi-online.co.uk.

For further information, contact:
Jay Clements
Tel: +44 (0)20 7827 6734
Email: jclements@smi-online.co.uk